Table 3 Susceptibility in % in relationship to number of risk factors (RF)
Overall | 0 RF | 1 RF | > = 2 RF | |
|---|---|---|---|---|
(n = 137) | (n = 41) | (n = 40) | (n = 56) | |
Ciprofloxacin | 71.5% | 90.2% | 80.0% | 51.8% |
Pip/taz | 80.3% | 87.8% | 80.0% | 75.0% |
Gentamicin | 84.7% | 95.1% | 87.5% | 75.0% |
Ceftazidime | 85.4% | 100% | 82.5% | 76.8% |
Cefpodoxime | 76.6% | 97.6% | 77.5% | 60.7% |
Cefuroxime | 73.7% | 97.6% | 77.5% | 53.7% |
Imipenem | 96.4% | 100% | 100% | 91.1% |